Sarath Babu Nukala

Sarath Babu Nukala

Auto-generated profile, based on publicly available information

Sarath Babu Nukala

Department of Pharmacology & Regenerative Medicine University of Illinois College of Medicine Chicago IL 60612 USA

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 March 2016 in Proteomics
Verified
Journal Article
Closed access
PDF file
NBNukala Sarath Babu
Nukala Sarath Babu
CMCh Lakshmi N. Murthy
Ch Lakshmi N. Murthy
SKSameera Kakara
Sameera Kakara
RSRahul Sharma
Rahul Sharma
CSCherukuvada V. Brahmendra Swamy
Cherukuvada V. Brahmendra Swamy
MIMohammed Idris
Mohammed Idris

1 August 2016 in The Spine Journal
Verified
Journal Article
Closed access
NBNukala Sarath Babu
Nukala Sarath Babu
SKSivaraman Krishnan
Sivaraman Krishnan
CSCherukuvada V. Brahmendra Swamy
Cherukuvada V. Brahmendra Swamy
GSGoli P. Venkata Subbaiah
Goli P. Venkata Subbaiah
ARAnnapareddy V. Gurava Reddy
Annapareddy V. Gurava Reddy
MIMohammed Idris
Mohammed Idris

12 March 2016 in Wound Repair and Regeneration
Verified
Journal Article
Closed access
PDF file
SSSandeep Saxena
Sandeep Saxena
SPSruthi Purushothaman
Sruthi Purushothaman
VMVuppalapaty Meghah Msc
Vuppalapaty Meghah Msc
BBBhawna Bhatti
Bhawna Bhatti
APAkhila Poruri
Akhila Poruri
MIMohammed Idris
Mohammed Idris

10 March 2021 in Scientific Reports
Verified
Journal Article
Open access
PDF file
SNSarath Babu Nukala
Sarath Babu Nukala
OTOlga Tura-Ceide
Olga Tura-Ceide
GAGiancarlo Aldini
Giancarlo Aldini
VSValérie F. E. D. Smolders
Valérie F. E. D. Smolders
IBIsabel Blanco
Isabel Blanco
Alfonsina D'AmatoAlfonsina D'Amato
Alfonsina D'Amato
Chronic thromboembolic pulmonary hypertension (CTEPH) is a vascular disease characterized by the presence of organized thromboembolic material in pulmonary arteries leading to increased vascular resistance, heart failure and death. Dysfunction of endothelial cells is involved in CTEPH. The present study describes for the first time the molecular processes underlying endothelial dysfunction in the development of the CTEPH. The advanced analytical approach and the protein network analyses of patient derived CTEPH endothelial cells allowed the quantitation of 3258 proteins. The 673 differentially regulated proteins were associated with functional and disease protein network modules. The protein network analyses resulted in the characterization of dysregulated pathways associated with endothelial dysfunction, such as mitochondrial dysfunction, oxidative phosphorylation, sirtuin signaling, inflammatory response, oxidative stress and fatty acid metabolism related pathways. In addition, the quantification of advanced oxidation protein products, total protein carbonyl content, and intracellular reactive oxygen species resulted increased attesting the dysregulation of oxidative stress response. In conclusion this is the first quantitative study to highlight the involvement of endothelial dysfunction in CTEPH using patient samples and by network medicine approach.

1 June 2020 in Journal of Pharmaceutical and Biomedical Analysis
Verified
Journal Article
Closed access
Silvia RadrezzaSilvia Radrezza
Silvia Radrezza
GBGiovanna Baron
Giovanna Baron
SNSarath Babu Nukala
Sarath Babu Nukala
GDGabriele Depta
Gabriele Depta
Giancarlo AldiniGiancarlo Aldini
Giancarlo Aldini
Alfonsina D'AmatoAlfonsina D'Amato
Alfonsina D'Amato

1 October 2019 in Hypertension
Verified
Journal Article
Closed access
PDF file
SNSarath Babu Nukala
Sarath Babu Nukala
LRLuca Regazzoni
Luca Regazzoni
GAGiancarlo Aldini
Giancarlo Aldini
EZErika Zodda
Erika Zodda
Olga Tura-CeideOlga Tura-Ceide
Olga Tura-Ceide
ADAlfonsina D’aMato
Alfonsina D’aMato
Endothelial dysfunction is one of the primary factors in the onset and progression of atherothrombosis resulting in acute myocardial infarction (AMI). However, the pathological and cellular mechanisms of endothelial dysfunction in AMI have not been systematically studied. Protein expression profiling in combination with a protein network analysis was used by the mass spectrometry-based label-free quantification approach. This identified and quantified 2246 proteins, of which 335 were differentially regulated in coronary arterial endothelial cells from patients with AMI compared with controls. The differentially regulated protein profiles reveal the alteration of (1) metabolism of RNA, (2) platelet activation, signaling, and aggregation, (3) neutrophil degranulation, (4) metabolism of amino acids and derivatives, (5) cellular responses to stress, and (6) response to elevated platelet cytosolic Ca 2+ pathways. Increased production of oxidants and decreased production of antioxidant biomarkers as well as downregulation of proteins with antioxidant properties suggests a role for oxidative stress in mediating endothelial dysfunction during AMI. In conclusion, this is the first quantitative proteomics study to evaluate the cellular mechanisms of endothelial dysfunction in patients with AMI. A better understanding of the endothelial proteome and pathophysiology of AMI may lead to the identification of new drug targets.